Difference between revisions of "Zaidi AH, et al. Ann. Surg. (2017) cited as Ref 365 in DOI: 10.1038/s41392-020-0110-5 (Q9628)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Volume (P103): 266, #quickstatements; #temporary_batch_1590009084631)
(‎Created claim: title (P93): PI3K/mTOR dual inhibitor LY3023414 demonstrates potent antitumor efficacy against esophageal adenocarcinoma in a rat model, #quickstatements; #temporary_batch_1590010982689)
Property / title
 +
PI3K/mTOR dual inhibitor LY3023414 demonstrates potent antitumor efficacy against esophageal adenocarcinoma in a rat model (English)
Property / title: PI3K/mTOR dual inhibitor LY3023414 demonstrates potent antitumor efficacy against esophageal adenocarcinoma in a rat model (English) / rank
 +
Normal rank

Revision as of 22:00, 20 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Zaidi AH, et al. Ann. Surg. (2017) cited as Ref 365 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Zaidi AH
    0 references
    0 references
    2017
    0 references
    Ann. Surg.
    0 references
    266
    0 references
    PI3K/mTOR dual inhibitor LY3023414 demonstrates potent antitumor efficacy against esophageal adenocarcinoma in a rat model (English)
    0 references